[ Price : $8.95]
The U.S. Pharmacopeial Convention finalizes a standards revision to heparin sodium injections and heparin lock flush solutions tha...[ Price : $8.95]
A legal analysis by Dechert LLP attorney Michelle Hart Yeary reviews how an unusual generic design defect claim survived a preempt...[ Price : $8.95]
FDA says a recent review of data show bleeding rates associated with new use of Pradaxa do not appear to be higher than bleeding r...[ Price : $8.95]
FDA approves updates to Mercks Victrelis (boceprevir) package insert and Medication Guide to include postmarketing information ab...[ Price : $8.95]
FDA expands the use of Janssen Pharmaceuticals Xarelto (rivaroxaban) to include treating deep vein thrombosis or pulmonary emboli...[ Price : $8.95]
FDA says it has the option to extend user fee review action dates by two days due to the unexpected agency closure 10/29-30 becaus...[ Price : $8.95]
CDERs Office of Prescription Drug Promotion sends the Burzynski Research Institute an untitled letter that cites Web sites, press ...[ Price : $8.95]
CDER Office of Prescription Drug Promotion cites ONY Inc.s Web pages and a promotional video for Infasurf.